Long‐term duration and safety of Radiesse (+) for the treatment of jawline
Journal of Cosmetic Dermatology · 2024-10 · 23 (10) · 3202-3209
DOI: 10.1111/jocd.16436 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 27.06.2024. Verfasst von Jeremy B Green und 6 weiteren Autor:innen. Beteiligte Einrichtung: Skin Research Institute and Skin Associates of South Florida, Coral Gables, Florida, USA. Hauptthemen laut MEDLINE: Durapatite, Cosmetic Techniques, Skin Aging, Carboxymethylcellulose Sodium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merz Aesthetics North America.
Abstract (Originalsprache)
Background
Calcium hydroxyapatite (CaHA)‐carboxymethylcellulose (CMC)+ has unique properties that make it optimal for lifting, contouring, and defining the jawline. This long‐term follow‐up of a randomized, multicenter, rater‐blinded trial reports efficacy and safety of CaHA‐CMC(+) through 48 and up to 60 weeks post‐treatment.
Methods
Eligible patients were randomized (2:1) to the treatment or the control/delayed treatment group to receive CaHA‐CMC(+) injections in both jawlines. While touch‐ups were permitted 4 weeks post‐treatment for both groups, only the treatment group was eligible for optional retreatment after 48 weeks. The primary outcome was ≥1‐point improvement on both jawlines on the Merz Jawline Assessment Scale (MJAS); secondary endpoints included the Subject Global Aesthetic Improvement Scale (SGAIS) among others. Post hoc analysis included pooling up to 48‐week data from the combined treatment and control/delayed groups and 60‐week data for the treatment group.
Results
Overall, 175 received treatment. MJAS responder rates were 77.9%, 78.7%, and 62.9% at 12, 24, and 48 weeks post‐treatment, respectively. Responder rate on the MJAS at 60 weeks was 74.6% for those who received retreatment and 43.5% for those patients who received only the initial and touchup treatments. SGAIS scores demonstrated 93.4%, 85.6%, and 68.5% of patients rated themselves very much improved after 12, 24, and 48 weeks, respectively. Adverse events consisted of procedure or CaHA‐CMC(+)‐related events that were mostly resolved and overwhelmingly mild.
Conclusions
CaHA‐CMC(+) produced clinically meaningful and long‐lasting improvements in jawline contour and was well tolerated in patients through 60 weeks. Trial Registration ClinicalTrials.gov Identifier: NCT03583359.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skin Research Institute and Skin Associates of South Florida, Coral Gables, Florida, USA.
- Del Campo Dermatology, Miami, Florida, USA.
- Ocean Drive Plastic Surgery and MedSpa, Vero Beach, Florida, USA.
- Florida State University College of Medicine, Tallahassee, Florida, USA.
- Icahn School of Medicine, Mount Sinai Hospital, New York, New York, USA.
- Merz North America, Inc., Raleigh, North Carolina, USA.
Förderung
- Merz Aesthetics North America
Zitieren
APA
Green, J. B., Del Campo, R., Durkin, A. J., Funt, D. K., Nasrallah, N., Martinez, K., & Moradi, A. (2024). Long‐term duration and safety of Radiesse (+) for the treatment of jawline. Journal of Cosmetic Dermatology, 23(10), 3202-3209. https://doi.org/10.1111/jocd.16436
Vancouver
Green JB, Del Campo R, Durkin AJ, Funt DK, Nasrallah N, Martinez K, et al. Long‐term duration and safety of Radiesse (+) for the treatment of jawline. Journal of Cosmetic Dermatology. 2024;23(10):3202-3209. doi:10.1111/jocd.16436
BibTeX
@article{Green2024,
author = {Green, Jeremy B and Del Campo, Roberta and Durkin, Alan J and Funt, David K and Nasrallah, Nicole and Martinez, Keith and Moradi, Amir},
title = {Long‐term duration and safety of Radiesse (+) for the treatment of jawline},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {10},
pages = {3202--3209},
doi = {10.1111/jocd.16436}
}
EUVIMED